President Donld Trump petitioned the Supreme Court to reinstate an FDA rule mandating a doctor's office visit for patients to obtain mifepristone, which is used to terminate an early pregnancy. (Photo: Robin Marty/Flickr)
Amid Pandemic, Trump Petitions Supreme Court to Make Potential Covid-19 Exposure 'the Price of Abortion Care'
"We've already blocked this policy in two federal courts—and we plan to do so again," said the ACLU.
Potentially subjecting patients to Covid-19 risks in the interest of violating the constitutional right to seek an abortion, President Donald Trump on Wednesday petitioned the U.S. Supreme Court to reinstate a rule requiring patients to see a doctor in person before obtaining a medication used to provide abortion care.
The ACLU filed a lawsuit last month to suspend the Food and Drug Administration's (FDA) restriction on behalf of the American College of Obstetricians and Gynecologists (ACOG), New York State Academy of Family Physicians, and other reproductive healthcare providers and rights groups.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk."
--Julia Kaye, ACLU
The organization successfully obtained an injunction when the U.S. District Court of Maryland ruled that the rule should be suspended to protect patients from potential exposure to Covid-19 when they make an unnecessary trip to obtain the medications, mifepristone, which is used to terminate a pregnancy in the first trimester.
The Fourth Circuit Court of Appeals denied the Trump administration's request to stay the lower court's ruling, leading to the president's action on Wednesday.
"With Covid-19 raging across the nation--and despite being rebuffed twice in the courts--the Trump administration refuses to end its crusade to subject abortion patients and their families to entirely unnecessary exposure risks," said Julia Kaye, staff attorney with the ACLU's Reproductive Freedom Project. "Forcing patients to travel during a pandemic just to pick up a pill is irrational and dangerous, which is why the medical community uniformly opposes this senseless rule."
"We've already blocked this policy in two federal courts--and we plan to do so again," tweeted the organization.
Dr. Daniel Grossman, director of Advancing New Standards in Reproductive Health (ANSIRH), slammed the FDA for not following "the scientific evidence" which showed patients can safely use mifepristone to terminate a pregnancy without the burden of visiting a physician in person first.
In July, the U.S. District Court of Maryland ruled that patients can safely obtain the medication through the mail under supervision of a healthcare provider, and can consult with a physician in a telehealth appointment to avoid exposure to Covid-19 in a clinic or on public transportation.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk," Kaye said Wednesday.
We are at a crossroads
This country and this world are at a monumental crossroads. In a few short weeks, US voters will have an opportunity to beat back the forces of fascism and confront the billionaires who are rigging the economy, our media system, and our democracy, making it increasingly impossible for ordinary people to get by. We’re not just talking about the election. We’re talking about what must be done once these fascist elements are vanquished from power. We need a bolder set of solutions than what either major party has so far been willing to offer and a working-class movement ready to fight like hell for it. Trump didn't emerge from nowhere. The conditions that fueled MAGA authoritarianism were created by decades of radical neoliberal economic policies and a corrupt political system dominated by corporate interests. They slashed taxes on the super-rich, promising that the benefits would trickle down. They said giveaways to the corporate titans would make life more affordable for the rest of us. It was all bullshit. And when a bitter, betrayed populace searches for someone to blame, right-wing demagogues have little trouble finding scapegoats. People know when they're being lied to, but you won't hear any of this from the corporate media. Only independent journalism—powered and funded by people who believe in building a better world—can deliver truly trustworthy daily news. Our Fall Campaign is underway, and we need your help. To power our newsroom through the rest of the year, we need to raise $125,000 by midnight on October 31. So if you share our vision, please contribute whatever you can to sustain our work. |
Potentially subjecting patients to Covid-19 risks in the interest of violating the constitutional right to seek an abortion, President Donald Trump on Wednesday petitioned the U.S. Supreme Court to reinstate a rule requiring patients to see a doctor in person before obtaining a medication used to provide abortion care.
The ACLU filed a lawsuit last month to suspend the Food and Drug Administration's (FDA) restriction on behalf of the American College of Obstetricians and Gynecologists (ACOG), New York State Academy of Family Physicians, and other reproductive healthcare providers and rights groups.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk."
--Julia Kaye, ACLU
The organization successfully obtained an injunction when the U.S. District Court of Maryland ruled that the rule should be suspended to protect patients from potential exposure to Covid-19 when they make an unnecessary trip to obtain the medications, mifepristone, which is used to terminate a pregnancy in the first trimester.
The Fourth Circuit Court of Appeals denied the Trump administration's request to stay the lower court's ruling, leading to the president's action on Wednesday.
"With Covid-19 raging across the nation--and despite being rebuffed twice in the courts--the Trump administration refuses to end its crusade to subject abortion patients and their families to entirely unnecessary exposure risks," said Julia Kaye, staff attorney with the ACLU's Reproductive Freedom Project. "Forcing patients to travel during a pandemic just to pick up a pill is irrational and dangerous, which is why the medical community uniformly opposes this senseless rule."
"We've already blocked this policy in two federal courts--and we plan to do so again," tweeted the organization.
Dr. Daniel Grossman, director of Advancing New Standards in Reproductive Health (ANSIRH), slammed the FDA for not following "the scientific evidence" which showed patients can safely use mifepristone to terminate a pregnancy without the burden of visiting a physician in person first.
In July, the U.S. District Court of Maryland ruled that patients can safely obtain the medication through the mail under supervision of a healthcare provider, and can consult with a physician in a telehealth appointment to avoid exposure to Covid-19 in a clinic or on public transportation.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk," Kaye said Wednesday.
Potentially subjecting patients to Covid-19 risks in the interest of violating the constitutional right to seek an abortion, President Donald Trump on Wednesday petitioned the U.S. Supreme Court to reinstate a rule requiring patients to see a doctor in person before obtaining a medication used to provide abortion care.
The ACLU filed a lawsuit last month to suspend the Food and Drug Administration's (FDA) restriction on behalf of the American College of Obstetricians and Gynecologists (ACOG), New York State Academy of Family Physicians, and other reproductive healthcare providers and rights groups.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk."
--Julia Kaye, ACLU
The organization successfully obtained an injunction when the U.S. District Court of Maryland ruled that the rule should be suspended to protect patients from potential exposure to Covid-19 when they make an unnecessary trip to obtain the medications, mifepristone, which is used to terminate a pregnancy in the first trimester.
The Fourth Circuit Court of Appeals denied the Trump administration's request to stay the lower court's ruling, leading to the president's action on Wednesday.
"With Covid-19 raging across the nation--and despite being rebuffed twice in the courts--the Trump administration refuses to end its crusade to subject abortion patients and their families to entirely unnecessary exposure risks," said Julia Kaye, staff attorney with the ACLU's Reproductive Freedom Project. "Forcing patients to travel during a pandemic just to pick up a pill is irrational and dangerous, which is why the medical community uniformly opposes this senseless rule."
"We've already blocked this policy in two federal courts--and we plan to do so again," tweeted the organization.
Dr. Daniel Grossman, director of Advancing New Standards in Reproductive Health (ANSIRH), slammed the FDA for not following "the scientific evidence" which showed patients can safely use mifepristone to terminate a pregnancy without the burden of visiting a physician in person first.
In July, the U.S. District Court of Maryland ruled that patients can safely obtain the medication through the mail under supervision of a healthcare provider, and can consult with a physician in a telehealth appointment to avoid exposure to Covid-19 in a clinic or on public transportation.
"We hope the Supreme Court will deny the Trump administration's cruel attempt to score political points by putting people seeking essential reproductive health care at needless risk," Kaye said Wednesday.